Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Azura Ophthalmics Ltd.
Azura Ophthalmics to Present New Data Supporting the Potential of AZR-MD-001 to be the First Ophthalmic Keratolytic for Ocular Surface Diseases
March 28, 2024
From
Azura Ophthalmics Ltd.
Via
Business Wire
Azura Ophthalmics to Present New Data on AZR-MD-001 in Meibomian Gland Dysfunction at American Society of Cataract and Refractive Surgery and Association for Research in Vision and Ophthalmology Annual Meetings
April 20, 2023
From
Azura Ophthalmics Ltd.
Via
Business Wire
Azura Ophthalmics Announces Participation at the 2023 SVB Securities Global Biopharma Conference
January 17, 2023
From
Azura Ophthalmics Ltd.
Via
Business Wire
Azura Ophthalmics Presents Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction at Ophthalmology Innovation Summit XII
December 09, 2022
From
Azura Ophthalmics Ltd.
Via
Business Wire
Azura Ophthalmics Announces Participation at Upcoming Investor Conferences
November 21, 2022
From
Azura Ophthalmics Ltd.
Via
Business Wire
Azura Ophthalmics Announces Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction
November 17, 2022
From
Azura Ophthalmics Ltd.
Via
Business Wire
Azura Ophthalmics Expands Broad Intellectual Property Portfolio to 12 U.S. and European Patents
October 19, 2022
From
Azura Ophthalmics Ltd.
Via
Business Wire
Azura Ophthalmics Provides Update on AZR-MD-001 Phase 2 Clinical Program Targeting Meibomian Gland Dysfunction
September 28, 2022
From
Azura Ophthalmics Ltd.
Via
Business Wire
Azura Ophthalmics Announces Formation of Scientific Advisory Board (SAB)
September 21, 2022
From
Azura Ophthalmics Ltd.
Via
Business Wire
Azura Ophthalmics Secures Grant to Evaluate AZR-MD-001 for Improved Vision Quality Related to Contact Lens Discomfort
September 07, 2022
From
Azura Ophthalmics Ltd.
Via
Business Wire
Azura Ophthalmics Appoints Biopharma Industry Veteran Steven Altschuler, M.D. as Chair of the Board
September 07, 2021
From
Azura Ophthalmics Ltd.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.